---
title: "Faith Long Crystal expects a net loss of 150 million to 250 million yuan for the fiscal year 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225957568.md"
description: "According to the Zhitong Finance APP, Faith Long Crystal has released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of RMB 150 million to RMB 250 million; the net loss after deducting non-recurring gains and losses is expected to be RMB 155 million to RMB 255 million"
datetime: "2025-01-23T08:29:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225957568.md)
  - [en](https://longbridge.com/en/news/225957568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225957568.md)
generator: "portal-rs"
---

# Faith Long Crystal expects a net loss of 150 million to 250 million yuan for the fiscal year 2024

According to the Zhitong Finance APP, Faith Long Crystal (300460.SZ) released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of RMB 150 million to RMB 250 million for the year 2024; the net loss after deducting non-recurring gains and losses is expected to be RMB 155 million to RMB 255 million

### Related Stocks

- [300460.CN](https://longbridge.com/en/quote/300460.CN.md)

## Related News & Research

- [Keynes launches KAI analysis layer for Kortex](https://longbridge.com/en/news/299067380.md)
- [Nanoscope Therapeutics to Present Long-Term MCO-010 Data at the 59th Annual Retina Society Meeting](https://longbridge.com/en/news/299039207.md)
- [Husband-Wife Duo Turn Dream into Reality by Opening a Pet Supplies Plus in Brookhaven](https://longbridge.com/en/news/298934768.md)
- [REG - Wellington Mngmnt Gp Permanent TSB Group - Form 8.3 - Permanent TSB Group Holdings](https://longbridge.com/en/news/298708789.md)
- [Dogwood Therapeutics completes enrollment in Halneuron Phase 2b chemotherapy-induced neuropathic pain trial](https://longbridge.com/en/news/298920470.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**